Clinical Trial

Assessment of DOT Spectacles in Chinese Children Extension

Study acronym: CATHAY Ext
Recruiting
View on ClinicalTrials.gov →
Summary
This is a randomized, controlled, open-label, evaluator-blinded, multicenter, clinical trial of 12-months duration to evaluate the continued safety and efficacy of Diffusion Optics Technology (DOT) spectacle lenses in reducing the progression of juvenile myopia in children of Chinese origin.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-05-28; most recent amendment 2025-12-24.
Trial Details
NCT Number NCT07008001
Lead Sponsor SightGlass Vision, Inc.
Conditions Juvenile Myopia, Myopia
Enrollment 175 participants
Start Date 2025-08-01
Primary Completion 2026-09-30 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-12-29